{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:34:27Z","timestamp":1791272067281,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,1,4]],"date-time":"2013-01-04T00:00:00Z","timestamp":1357257600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s40266-012-0045-9","type":"journal-article","created":{"date-parts":[[2013,1,3]],"date-time":"2013-01-03T08:45:27Z","timestamp":1357202727000},"page":"113-118","source":"Crossref","is-referenced-by-count":15,"title":["Benzodiazepines in Geriatric Psychiatry"],"prefix":"10.1007","volume":"30","author":[{"given":"Gudrun","family":"H\u00f8iseth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari Midtb\u00f8","family":"Kristiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Kvande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Tanum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Lorentzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helge","family":"Refsum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,4]]},"reference":[{"issue":"6","key":"45_CR1","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1046\/j.0306-5251.2001.01401.x","volume":"51","author":"I Barat","year":"2001","unstructured":"Barat I, Andreasen F, Damsgaard EM. Drug therapy in the elderly: what doctors believe and patients actually do. Br J Clin Pharmacol. 2001;51(6):615\u201322.","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"45_CR2","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/qshc.2005.015347","volume":"15","author":"T Vira","year":"2006","unstructured":"Vira T, Colquhoun M, Etchells E. Reconcilable differences: correcting medication errors at hospital admission and discharge. Qual Saf Health Care. 2006;15(2):122\u20136.","journal-title":"Qual Saf Health Care"},{"issue":"6","key":"45_CR3","first-page":"810","volume":"124","author":"S Rognstad","year":"2004","unstructured":"Rognstad S, Straand J. Do general practitioners know what medication community nurses give their shared patients? [in Norwegian]. Tidsskr Nor Laegeforen. 2004;124(6):810\u20132.","journal-title":"Tidsskr Nor Laegeforen"},{"issue":"1","key":"45_CR4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.coph.2004.08.006","volume":"5","author":"KA Wafford","year":"2005","unstructured":"Wafford KA. GABAA receptor subtypes: any clues to the mechanism of benzodiazepine dependence? Curr Opin Pharmacol. 2005;5(1):47\u201352.","journal-title":"Curr Opin Pharmacol"},{"issue":"2","key":"45_CR5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00004850-199400920-00008","volume":"9","author":"J Ingum","year":"1994","unstructured":"Ingum J, Pettersen G, Sager G, Morland J. Relationship between unbound plasma concentrations and various psychomotor and subjective effects after intakes of diazepam and flunitrazepam. Int Clin Psychopharmacol. 1994;9(2):115\u201321.","journal-title":"Int Clin Psychopharmacol"},{"issue":"2","key":"45_CR6","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1017\/S0033291700007911","volume":"18","author":"S Golombok","year":"1988","unstructured":"Golombok S, Moodley P, Lader M. Cognitive impairment in long-term benzodiazepine users. Psychol Med. 1988;18(2):365\u201374.","journal-title":"Psychol Med"},{"issue":"1","key":"45_CR7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2165\/00023210-200418010-00004","volume":"18","author":"MJ Barker","year":"2004","unstructured":"Barker MJ, Greenwood KM, Jackson M, Crowe SF. Cognitive effects of long-term benzodiazepine use: a meta-analysis. CNS Drugs. 2004;18(1):37\u201348.","journal-title":"CNS Drugs"},{"issue":"4","key":"45_CR8","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1017\/S1041610211002031","volume":"24","author":"MP Sylvestre","year":"2012","unstructured":"Sylvestre MP, Abrahamowicz M, Capek R, Tamblyn R. Assessing the cumulative effects of exposure to selected benzodiazepines on the risk of fall-related injuries in the elderly. Int Psychogeriatr. 2012;24(4):577\u201386.","journal-title":"Int Psychogeriatr"},{"issue":"2","key":"45_CR9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0376-8716(91)90044-Y","volume":"29","author":"B Wolf","year":"1991","unstructured":"Wolf B, Griffiths RR. Physical dependence on benzodiazepines: differences within the class. Drug Alcohol Depend. 1991;29(2):153\u20136.","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"45_CR10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-0031-1286287","volume":"44","author":"C Hiemke","year":"2011","unstructured":"Hiemke C, Baumann P, Bergemann N, Conca A, Dietmaier O, Egberts K, et al. AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011. Pharmacopsychiatry. 2011;44(6):195\u2013235.","journal-title":"Pharmacopsychiatry"},{"issue":"3","key":"45_CR11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/02813430902992215","volume":"27","author":"S Rognstad","year":"2009","unstructured":"Rognstad S, Brekke M, Fetveit A, Spigset O, Wyller TB, Straand J. The Norwegian General Practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patients: a modified Delphi study. Scand J Prim Health Care. 2009;27(3):153\u20139.","journal-title":"Scand J Prim Health Care"},{"issue":"6567","key":"45_CR12","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/bmj.294.6567.289","volume":"294","author":"WJ Gilchrist","year":"1987","unstructured":"Gilchrist WJ, Lee YC, Tam HC, Macdonald JB, Williams BO. Prospective study of drug reporting by general practitioners for an elderly population referred to a geriatric service. Br Med J (Clin Res Ed). 1987;294(6567):289\u201390.","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"2","key":"45_CR13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/03602530902722679","volume":"41","author":"U Klotz","year":"2009","unstructured":"Klotz U. Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev. 2009;41(2):67\u201376.","journal-title":"Drug Metab Rev"},{"issue":"7","key":"45_CR14","first-page":"447","volume":"58","author":"M Schulz","year":"2003","unstructured":"Schulz M, Schmoldt A. Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics. Pharmazie. 2003;58(7):447\u201374.","journal-title":"Pharmazie"},{"issue":"2","key":"45_CR15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/pds.2214","volume":"121","author":"NC Ineke","year":"2012","unstructured":"Ineke NC, Skurtveit S, Berg C. Polypharmacy of potentially addictive medication in the older persons: quantifying usage. Pharmacoepidemiol Drug Saf. 2012;121(2):199\u2013206.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"45_CR16","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1360-0443.2006.01397.x","volume":"101","author":"IR Rockett","year":"2006","unstructured":"Rockett IR, Putnam SL, Jia H, Smith GS. Declared and undeclared substance use among emergency department patients: a population-based study. Addiction. 2006;101(5):706\u201312.","journal-title":"Addiction"},{"issue":"1","key":"45_CR17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/09595230500125138","volume":"24","author":"L Elliott","year":"2005","unstructured":"Elliott L, Glenday J, Freeman L, Ajeda D, Johnston B, Christie M, et al. Reducing diazepam prescribing for illicit drug users: a randomised control study. Drug Alcohol Rev. 2005;24(1):25\u201331.","journal-title":"Drug Alcohol Rev"},{"issue":"4","key":"45_CR18","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/BF02246023","volume":"125","author":"P Hayward","year":"1996","unstructured":"Hayward P, Wardle J, Higgitt A, Gray J. Changes in \u2018withdrawal symptoms\u2019 following discontinuation of low-dose diazepam. Psychopharmacology (Berl). 1996;125(4):392\u20137.","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"45_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1037\/a0018407","volume":"18","author":"BA Kleykamp","year":"2010","unstructured":"Kleykamp BA, Griffiths RR, Mintzer MZ. Dose effects of triazolam and alcohol on cognitive performance in healthy volunteers. Exp Clin Psychopharmacol. 2010;18(1):1\u201316.","journal-title":"Exp Clin Psychopharmacol"},{"issue":"1","key":"45_CR20","first-page":"120","volume":"234","author":"JD Roache","year":"1985","unstructured":"Roache JD, Griffiths RR. Comparison of triazolam and pentobarbital: performance impairment, subjective effects and abuse liability. J Pharmacol Exp Ther. 1985;234(1):120\u201333.","journal-title":"J Pharmacol Exp Ther"},{"issue":"7","key":"45_CR21","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/01.fbp.0000172736.11994.3c","volume":"16","author":"MZ Mintzer","year":"2005","unstructured":"Mintzer MZ, Griffiths RR. An abuse liability comparison of flunitrazepam and triazolam in sedative drug abusers. Behav Pharmacol. 2005;16(7):579\u201384.","journal-title":"Behav Pharmacol"},{"issue":"3","key":"45_CR22","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0887-6177(03)00096-9","volume":"19","author":"MJ Barker","year":"2004","unstructured":"Barker MJ, Greenwood KM, Jackson M, Crowe SF. Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: a meta-analysis. Arch Clin Neuropsychol. 2004;19(3):437\u201354.","journal-title":"Arch Clin Neuropsychol"},{"issue":"2","key":"45_CR23","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0001-4575(02)00153-7","volume":"36","author":"OH Drummer","year":"2004","unstructured":"Drummer OH, Gerostamoulos J, Batziris H, Chu M, Caplehorn J, Robertson MD, et al. The involvement of drugs in drivers of motor vehicles killed in Australian road traffic crashes. Accid Anal Prev. 2004;36(2):239\u201348.","journal-title":"Accid Anal Prev"},{"issue":"5","key":"45_CR24","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0001-4575(99)00110-4","volume":"32","author":"MC Longo","year":"2000","unstructured":"Longo MC, Hunter CE, Lokan RJ, White JM, White MA. The prevalence of alcohol, cannabinoids, benzodiazepines and stimulants amongst injured drivers and their role in driver culpability: part II. The relationship between drug prevalence and drug concentration, and driver culpability. Accid Anal Prev. 2000;32(5):623\u201332.","journal-title":"Accid Anal Prev"},{"issue":"10","key":"45_CR25","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1111\/j.1532-5415.2011.03591.x","volume":"59","author":"WD Finkle","year":"2011","unstructured":"Finkle WD, Der JS, Greenland S, Adams JL, Ridgeway G, Blaschke T, et al. Risk of fractures requiring hospitalization after an initial prescription for zolpidem, alprazolam, lorazepam, or diazepam in older adults. J Am Geriatr Soc. 2011;59(10):1883\u201390.","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"45_CR26","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1067\/mcp.2002.129318","volume":"72","author":"F Landi","year":"2002","unstructured":"Landi F, Cesari M, Russo A, Onder G, Sgadari A, Bernabei R. Benzodiazepines and the risk of urinary incontinence in frail older persons living in the community. Clin Pharmacol Ther. 2002;72(6):729\u201334.","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"45_CR27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1891\/1541-6577.25.2.127","volume":"25","author":"MG Titler","year":"2011","unstructured":"Titler MG, Shever LL, Kanak MF, Picone DM, Qin R. Factors associated with falls during hospitalization in an older adult population. Res Theory Nurs Pract. 2011;25(2):127\u201348.","journal-title":"Res Theory Nurs Pract"},{"issue":"Suppl. 9","key":"45_CR28","first-page":"31","volume":"66","author":"RR Griffiths","year":"2005","unstructured":"Griffiths RR, Johnson MW. Relative abuse liability of hypnotic drugs: a conceptual framework and algorithm for differentiating among compounds. J Clin Psychiatry. 2005;66(Suppl. 9):31\u201341.","journal-title":"J Clin Psychiatry"},{"issue":"7","key":"45_CR29","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1176\/ajp.141.7.848","volume":"141","author":"R Fontaine","year":"1984","unstructured":"Fontaine R, Chouinard G, Annable L. Rebound anxiety in anxious patients after abrupt withdrawal of benzodiazepine treatment. Am J Psychiatry. 1984;141(7):848\u201352.","journal-title":"Am J Psychiatry"},{"issue":"3","key":"45_CR30","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.jad.2011.10.016","volume":"136","author":"VR Jorgensen","year":"2012","unstructured":"Jorgensen VR. Benzodiazepine reduction in general practice: are the elderly neglected? J Affect Disord. 2012;136(3):1216\u201321.","journal-title":"J Affect Disord"},{"issue":"7","key":"45_CR31","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.sleep.2011.12.014","volume":"13","author":"CI Neutel","year":"2012","unstructured":"Neutel CI, Skurtveit S, Berg C. What is the point of guidelines? Benzodiazepine and z-hypnotic use by an elderly population. Sleep Med. 2012;13(7):893\u20137.","journal-title":"Sleep Med"},{"issue":"2","key":"45_CR32","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2125.2007.03017.x","volume":"65","author":"B Glintborg","year":"2008","unstructured":"Glintborg B, Poulsen HE, Dalhoff KP. The use of nationwide on-line prescription records improves the drug history in hospitalized patients. Br J Clin Pharmacol. 2008;65(2):265\u20139.","journal-title":"Br J Clin Pharmacol"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-012-0045-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40266-012-0045-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-012-0045-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T19:41:49Z","timestamp":1559504509000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40266-012-0045-9"}},"subtitle":["What Doctors Report and What Patients Actually Use"],"short-title":[],"issued":{"date-parts":[[2013,1,4]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["45"],"URL":"https:\/\/doi.org\/10.1007\/s40266-012-0045-9","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,4]]}}}